Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02850068 · ClinicalTrials.gov registry record · NA
Geniculate Artery Embolization for the Treatment of Knee Pain
A NA study, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT02850068 is a NA study that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 20 participants.
The verdict
NCT02850068, a NA study, has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
This study is to test a new treatment method, geniculate artery embolization (GAE), to reduce the severity of pain and disability caused by knee osteoarthritis.
Interventions
- DEVICE Geniculate Artery Embolization
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2017-01-25 |
| Est. Completion | 2018-08-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02850068
The ClinicalTrials.gov registry entry for NCT02850068 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Geniculate Artery Embolization is the first listed.
NCT02850068 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02850068 about?
NCT02850068 is a clinical study titled "Geniculate Artery Embolization for the Treatment of Knee Pain". This study is to test a new treatment method, geniculate artery embolization (GAE), to reduce the severity of pain and disability caused by knee osteoarthritis.
What is the current status of trial NCT02850068?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2017-01-25. Estimated completion is 2018-08-03.
What interventions are being tested in trial NCT02850068?
The interventions under investigation include: Geniculate Artery Embolization (DEVICE).
Who is sponsoring clinical trial NCT02850068?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.